![VAXELIS® Diphtheria, Tetanus, Pertussis (acellular, component), Hepatitis B (rDNA), Poliomyelitis (inactivated), and Haemophilus type b conjugate vaccine (adsorbed) - Sanofi Campus VAXELIS® Diphtheria, Tetanus, Pertussis (acellular, component), Hepatitis B (rDNA), Poliomyelitis (inactivated), and Haemophilus type b conjugate vaccine (adsorbed) - Sanofi Campus](https://www.campus.sanofi/dam/jcr:0c54500d-4d31-44eb-80bf-2e9a160f9824/Vaxelis-_2_.2023-07-17-15-30-18.webp)
VAXELIS® Diphtheria, Tetanus, Pertussis (acellular, component), Hepatitis B (rDNA), Poliomyelitis (inactivated), and Haemophilus type b conjugate vaccine (adsorbed) - Sanofi Campus
![WHO highlights role of screening and vaccination in reaching hepatitis B control targets - PHE Screening WHO highlights role of screening and vaccination in reaching hepatitis B control targets - PHE Screening](https://phescreening.blog.gov.uk/wp-content/uploads/sites/152/2020/10/Hep-B-leaflets-4.jpg)
WHO highlights role of screening and vaccination in reaching hepatitis B control targets - PHE Screening
![Maximising the effectiveness of therapeutic vaccines a step closer | UCL News - UCL – University College London Maximising the effectiveness of therapeutic vaccines a step closer | UCL News - UCL – University College London](https://www.ucl.ac.uk/news/sites/news/files/vaccine_2.jpg)